Bharat Parenterals (541096) Stock Overview
Engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
541096 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Bharat Parenterals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,550.55 |
| 52 Week High | ₹1,593.95 |
| 52 Week Low | ₹880.25 |
| Beta | 0.74 |
| 1 Month Change | 11.39% |
| 3 Month Change | 16.42% |
| 1 Year Change | 11.60% |
| 3 Year Change | 174.46% |
| 5 Year Change | 307.99% |
| Change since IPO | 871.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 541096 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 1.0% | -0.4% | -0.6% |
| 1Y | 11.6% | 15.5% | -0.1% |
Return vs Industry: 541096 underperformed the Indian Pharmaceuticals industry which returned 15.5% over the past year.
Return vs Market: 541096 exceeded the Indian Market which returned -0.1% over the past year.
Price Volatility
| 541096 volatility | |
|---|---|
| 541096 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in IN Market | 8.9% |
| 10% least volatile stocks in IN Market | 3.4% |
Stable Share Price: 541096 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 541096's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 404 | Bharatkumar Desai | bplindia.in |
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms.
Bharat Parenterals Limited Fundamentals Summary
| 541096 fundamental statistics | |
|---|---|
| Market cap | ₹10.56b |
| Earnings (TTM) | -₹154.07m |
| Revenue (TTM) | ₹3.23b |
Is 541096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 541096 income statement (TTM) | |
|---|---|
| Revenue | ₹3.23b |
| Cost of Revenue | ₹1.69b |
| Gross Profit | ₹1.54b |
| Other Expenses | ₹1.70b |
| Earnings | -₹154.07m |
Last Reported Earnings
Jun 30, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -22.36 |
| Gross Margin | 47.75% |
| Net Profit Margin | -4.77% |
| Debt/Equity Ratio | 46.9% |
How did 541096 perform over the long term?
See historical performance and comparisonDividends
Does 541096 pay a reliable dividends?
See 541096 dividend history and benchmarks| Bharat Parenterals dividend dates | |
|---|---|
| Ex Dividend Date | Sep 11 2026 |
| Dividend Pay Date | Oct 19 2026 |
| Days until Ex dividend | 0 days |
| Days until Dividend pay date | 38 days |
Does 541096 pay a reliable dividends?
See 541096 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/10 12:39 |
| End of Day Share Price | 2026/09/10 00:00 |
| Earnings | 2026/06/30 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bharat Parenterals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.